Abstract
BackgroundCinacalcet is approved for the treatment of hypercalcaemia in patients with primary hyperparathyroidism for which parathyroidectomy is contraindicated. At present, there is little information available on the administration of cinacalcet...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: European Journal of Hospital Pharmacy: Science and Practice
Paper Title
Journal
Date
